Keyphrases
CD4 T Cells
100%
Mouse Brain
100%
Brain Tumor
100%
PD-1 Blockade
100%
CD8+ T Cell Exhaustion
100%
PD-1 Blockade Therapy
100%
Glioblastoma
55%
GL261
44%
Exhausted CD8 T Cells
44%
CD40 Agonist
22%
Interferon-α (IFN-α)
11%
CD-8
11%
Cellular Compartments
11%
Treg
11%
Malignancy
11%
Survival Benefit
11%
CD8+
11%
Survival Analysis
11%
CD40
11%
CD4+ T Cells
11%
CD8+ T Cells
11%
Programmed Death-ligand 1 (PD-L1)
11%
Immunotherapeutic Approaches
11%
Fatal Infection
11%
Microenvironment
11%
Agonist Treatment
11%
Combinational Therapy
11%
Single-cell RNA Sequencing (scRNA-seq)
11%
Combined Modality Therapy
11%
Tumor-infiltrating Lymphocytes
11%
Orthotopic Model
11%
Tumor-bearing Mice
11%
Agonism
11%
T-cell Phenotype
11%
CD4 Depletion
11%
CD4 Lymphopenia
11%
Neuroscience
T Cell
100%
CD4
100%
CD8
100%
Intracranial Tumor
100%
Mouse Brain
100%
Agonist
11%
Interferon
5%
Survival Analysis
5%
RNA Sequence
5%
Lymphocytopenia
5%
Lymphocyte
5%
Immunology and Microbiology
T-Helper Cell
100%
Cytotoxic T-Cell
100%
CD4
40%
C57BL 6 Mouse
20%
Agonist
20%
CD8
10%
interferon
10%
RNA Sequence
10%
T Cell Subset
10%
Lymphocytopenia
10%
Tumor-Infiltrating Lymphocytes
10%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
CD8
100%
CD4
100%
C57BL 6 Mouse
11%
Agonist
11%
RNA Sequence
5%
Tumor-Infiltrating Lymphocytes
5%
Interferon
5%
Pharmacology, Toxicology and Pharmaceutical Science
CD8 Antigen
100%
Intracranial Tumor
100%
Glioblastoma
50%
Neoplasm
20%
C57BL 6 Mouse
20%
Interferon
10%
RNA-Sequencing
10%
Lymphocytopenia
10%
Diseases
10%